MEDIPOST Co., Ltd. (KOSDAQ:078160)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,950.00
-220.00 (-2.40%)
Mar 28, 2025, 3:30 PM KST
25.00%
Market Cap 305.18B
Revenue (ttm) 70.66B
Net Income (ttm) -62.52B
Shares Out 34.10M
EPS (ttm) -1,834.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 78,583
Average Volume 152,535
Open 9,200.00
Previous Close 9,170.00
Day's Range 8,950.00 - 9,270.00
52-Week Range 5,450.00 - 15,180.00
Beta 0.29
RSI 46.47
Earnings Date Mar 21, 2025

About MEDIPOST

MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 078160
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.